Tag Archives: MDR-TB
New Delhi: Indian Spinal Injuries Centre treated an unusual case of a banker diagnosed with tuberculosis which subsequently spread to her bones making her limp with pain that was getting progressively worse.
Dr Srinivas Rao Ghattamaneni is a senior MSF MDR-TB/HIV doctor who recently returned from Ukraine after serving there as a tuberculosis (TB) specialist.
London: The number of cases of tuberculosis (TB) in India may be up to two to three times higher than current estimates, suggests a new study.
Antimicrobial resistance (AMR) is a global health threat, and it is estimated that by 2050, 10 million lives a year and a cumulative 100 trillion USD of economic output are at risk due to the rise of drug-resistant infections, if we do not find solutions to tackle the rise of drug resistant pathogens.
The World Health Organisation (WHO) recently announced new recommendations to speed up diagnosis and improve treatment outcomes for multi-drug resistant tuberculosis (MDR-TB) through the use of a novel rapid diagnostic test called MTBDRsl, and a shorter, cheaper 9-12 months treatment regimen. The new treatment regimen can be completed in 9-12 months — less than half the time required by the current 24 months treatment standard used worldwide.
New Delhi: Indian Red Cross Society, Irish Red Cross and University College Dublin (UCD) signed an agreement here on Tuesday to develop digital humanitarian application to prevent tuberculosis in India.
TB in India can be tackled with a joint effort of the private physicians, municipal corporation, and patient counselling. Early diagnosis and treatment along with nutritional supplements are needed. Control of diabetes is an important step towards controlling the spread of TB.
This article, one of the chapters of a new TB book called ‘Let’s Talk TB’ aimed at GPs in India (published by GP Clinics, available free at www.letstalktb.org) covers commonly asked questions by the primary care doctor about identification and referral of patients with suspected or confirmed DR-TB.
Washington: The White House released a plan to combat “global rise” of multidrug-resistant tuberculosis (MDR-TB). The plan released on Tuesday identified actions the US government will take in the next three or five years.
Even if the diagnostic hurdle is overcome, TB treatment in the private sector is far from standard. When private practitioners initiate anti-TB treatment (ATT), they tend to use drug regimens that are not recommended by WHO or the Standards of TB Care in India (STCI).